Statistics for β2-adrenergic agonists and doping: Where do we stand?
Total visits
| views | |
|---|---|
| β2-adrenergic agonists and doping: Where do we stand? | 101 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
| May 2025 | 1 |
| June 2025 | 0 |
| July 2025 | 1 |
File Visits
| views | |
|---|---|
| 2021_Lourenço O_Allergy_Correspondence.pdf(legacy) | 165 |
| 2021_Lourenço O_Allergy_Correspondence.pdf | 4 |
| Anexo IX - Trabalhos finais – “Perspectivas Cavaleira e (1).pdf(legacy) | 1 |
| DCAero_v2.png(legacy) | 1 |
| 8186_17631.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 23 |
| Portugal | 22 |
| Denmark | 14 |
| Australia | 6 |
| Greece | 6 |
| China | 5 |
| United Kingdom | 4 |
| Canada | 3 |
| Germany | 3 |
| Italy | 3 |
| Japan | 2 |
| Serbia | 2 |
| Russia | 2 |
| Brazil | 1 |
| France | 1 |
| Iraq | 1 |
| Iran | 1 |
| Moldova | 1 |
| Netherlands | 1 |
| Turkey | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Lisbon | 1 |
| Porto | 1 |